Skip to main content
. 2016 Jan 18;29(11):1646–1652. doi: 10.5713/ajas.15.0660

Figure 3.

Figure 3

Rapamycin inhibits elongation of very-long-chain fatty acids 1 (ELOVL1) expression in a time-dependent manner. Cells were treated with 100 nM rapamycin for 8 h and 24 h, and ELOVL1 expression was detected by enzyme-linked immunosorbent assay (ELISA) (A) and Western blot (B). (C) The resolved bands of western blot were quantified using Gel-Pro Analyzer 4.0 (Media Cybernetics, Inc., Rockville, MD, USA). ELOVL1 was down regulated with increasing treatment times (** p<0.01).